Forearm vasodilator reactivity in homozygous carriers of the 9p21·3 rs1333049 G>C polymorphism

European Journal of Clinical Investigation

Volumn 40, Issue 8, 2010, Pages 700-705

  Aschauer, Stefan ^a   Mittermayer, Friedrich ^a   Wagner, Claudia C ^a   Schmidt, Wolfgang M ^a   Brunner, Martin ^a   Haslacher, Helmuth ^a   Wolzt, Michael ^a   Müller, Markus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chromosome 9p21.3; coronary artery disease; forearm blood flow; human; vascular function

Indexed keywords

ACETYLCHOLINE; GENOMIC DNA; GLYCERYL TRINITRATE;

ADULT; ARTICLE; BRACHIAL ARTERY; CHROMOSOME 9P; CONTROLLED STUDY; DNA POLYMORPHISM; FOREARM BLOOD FLOW; GENE FREQUENCY; GENE LOCUS; GENETIC SCREENING; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR RESISTANCE; VASODILATATION;

ADULT; CHROMOSOMES, HUMAN, PAIR 9; FOREARM; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; POLYMORPHISM, GENETIC; REGIONAL BLOOD FLOW; VASODILATION;

EID: 77954463693     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02321.x     Document Type: Article

References (38)

1. Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007 25 : 1578 1582.
2. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007 316 : 1488 1491.
3. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007 357 : 443 453. (Pubitemid 47204873)
4. The Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447 : 661 678.
5. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007 316 : 1491 1493. (Pubitemid 46906618)
6. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 2008 52 : 378 384.
7. Bjorck HM, Lanne T, Alehagen U, Persson K, Rundkvist L, Hamsten A et al. Association of genetic variation on chromosome 9p21.3 and arterial stiffness. J Intern Med 2009 265 : 373 381.
8. Muendlein A, Saely CH, Rhomberg S, Sonderegger G, Loacker S, Rein P et al. Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease. Atherosclerosis 2009 205 : 174 180.
9. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000 101 : 1899 1906.
10. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002 106 : 653 658.
11. Takase B, Matsushima Y, Uehata A, Ishihara M, Kurita A. Endothelial dysfunction, carotid artery plaque burden, and conventional exercise-induced myocardial ischemia as predictors of coronary artery disease prognosis. Cardiovasc Ultrasound 2008 6 : 61.
12. Schunkert H, Gotz A, Braund P, McGinnis R, Tregouet DA, Mangino M et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008 117 : 1675 1684.
13. Farzaneh-Far R, Na B, Schiller NB, Whooley MA. Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009 205 : 492 496.
14. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010 40 : 35 53.
15. Pleiner J, Heere-Ress E, Langenberger H, Sieder AE, Bayerle-Eder M, Mittermayer F et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 2002 22 : 95 100.
16. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975 22 : 25 9.
17. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995 25 : 918 923.
18. Samani NJ, Deloukas P, Erdmann J, Hengstenberg C, Kuulasmaa K, McGinnis R et al. Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol 2009 29 : 774 780.
19. Chan NN, Vallance P, Colhoun HM. Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control. Arterioscler Thromb Vasc Biol 2003 23 : 1048 1054.
20. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007 316 : 1331 1336.
21. Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, Tararak E et al. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler Thromb Vasc Biol 2004 24 : 1391 1396.
22. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994 371 : 257 261.
23. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008 40 : 217 224.
24. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007 316 : 1341 1345.
25. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008 17 : 806 814.
26. Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, El Mokhtari NE et al. Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet 2009 5 : e1000378.
27. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Mohlke KL et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS ONE 2009 4 : e5027.
28. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007 67 : 3963 3969.
29. Samani NJ, Raitakari OT, Sipila K, Tobin MD, Schunkert H, Juonala M et al. Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis. Arterioscler Thromb Vasc Biol 2008 28 : 1679 1683.
30. Pleiner J, Wolzt M. Train your endothelium. Wien Klin Wochenschr 2001 113 : 635 637.
31. Kasprzak JD, Klosinska M, Drozdz J. Clinical aspects of assessment of endothelial function. Pharmacol Rep 2006 58 (Suppl. 33 40.
32. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998 32 : 123 127.
33. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001 104 : 191 196.
34. Bolad I, Delafontaine P. Endothelial dysfunction: its role in hypertensive coronary disease. Curr Opin Cardiol 2005 20 : 270 274.
35. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990 86 : 228 234.
36. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III., Panza JA. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998 97 : 851 856.
37. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992 90 : 2548 2554.
38. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000 101 : 948 954.